Matrix metalloproteinase (MMP)-3 polymorphism in patients with HBV related chronic liver disease

Digestive Diseases and Sciences

Volumn 53, Issue 3, 2008, Pages 823-829

  Shin, Hyun Phil ^a   Lee, Joung Il ^a   Jung, Joo Ho ^b   Yim, Sung Vin ^b   Kim, Hyun Jeong ^a   Cha, Jae Myung ^a   Park, Jong Beom ^a   Joo, Kwang Ro ^a   Hwang, Jae Seok ^c   Jang, Byoung Kuk ^c  

^a Kyung Hee University College of Medicine   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

^c Keimyung University School of Medicine   (South Korea)

Author keywords

Chronic hepatitis B; Liver fibrosis; Matrix metalloproteinases; MMP 3

Indexed keywords

GENOMIC DNA; STROMELYSIN;

ADULT; ARTICLE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; DISEASE COURSE; DNA EXTRACTION; DNA POLYMORPHISM; EXON; FEMALE; GENE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; KOREA; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MATRIX METALLOPROTEINASE 3 GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; THROMBOCYTE COUNT;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HEPATITIS B, CHRONIC; HUMANS; KOREA; LIVER CIRRHOSIS; MALE; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 39849084065     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-007-9937-7     Document Type: Article

References (31)

1. Burt AD (1993) C. L. Oakley lecture (1993). Cellular and molecular aspects of hepatic fibrosis. J Pathol 170:105-114
2. Arthur MJ (1995) Role of Ito cells in the degradation of matrix in liver. J Gastroenterol Hepatol 10(Suppl 1):S57-62
3. Senties-Gomez MD, Galvez-Gastelum FJ, Meza-Garcia E, Armendariz-Borunda J (2005) Hepatic fibrosis: role of matrix metalloproteases and TGFbeta. Gac Med Mex 141:315-322
4. Arthur MJ, Fibrogenesis II (2000) Metalloproteinases and their inhibitors in liver fibrosis. Am J Physiol Gastrointest Liver Physiol 279:G245-249
5. Wiencke K, Louka AS, Spurkland A, Vatn M, Schrumpf E, Boberg KM (2004) Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients. J Hepatol 41:209-214
6. Herbst H, Heinrichs O, Schuppan D, Milani S, Stein H (1991) Temporal and spatial patterns of transin/stromelysin RNA expression following toxic injury in rat liver. Virchows Arch B Cell Pathol Incl Mol Pathol 60:295-300
7. Humphries SE, Luong LA, Talmud PJ, Frick MH, Kesaniemi YA, Pasternack A, Taskinen MR, Syvanne M (1998) The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Lopid Coronary Angiography Trial. Atherosclerosis 139:49-56
8. Zhang B, Ye S, Herrmann SM, Eriksson P, de Maat M, Evans A, Arveiler D, Luc G, Cambien F, Hamsten A, Watkins H, Henney AM (1999) Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 99:1788-1794
9. Ye S, Watts GF, Mandalia S, Humphries SE, Henney AM (1995) Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis. Br Heart J 73:209-215
10. Ghilardi G, Biondi ML, DeMonti M, Turri O, Guagnellini E, Scorza R (2002) Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with carotid artery stenosis. Stroke 33:2408-2412
11. Ghilardi G, Biondi ML, Caputo M, Leviti S, DeMonti M, Guagnellini E, Scorza R (2002) A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility. Clin Cancer Res 8:3820-3823
12. Hinoda Y, Okayama N, Takano N, Fujimura K, Suehiro Y, Hamanaka Y, Hazama S, Kitamura Y, Kamatani N, Oka M (2002) Association of functional polymorphisms of matrix metalloproteinase (MMP)-1 and MMP-3 genes with colorectal cancer. Int J Cancer 102:526-529
13. Monvoisin A, Bisson C, Si-Tayeb K, Balabaud C, Desmouliere A, Rosenbaum J (2002) Involvement of matrix metalloproteinase type-3 in hepatocyte growth factor-induced invasion of human hepatocellular carcinoma cells. Int J Cancer 97:157-162
14. Chen L, Rydel TJ, Gu F, Dunaway CM, Pikul S, Dunham KM, Barnett BL (1999) Crystal structure of the stromelysin catalytic domain at 2.0 A resolution: inhibitor-induced conformational changes. J Mol Biol 293:545-557
15. Gooley PR, O'Connell JF, Marcy AI, Cuca GC, Salowe SP, Bush BL, Hermes JD, Esser CK, Hagmann WK, Springer JP et al (1994) The NMR structure of the inhibited catalytic domain of human stromelysin-1. Nat Struct Biol 1:111-118
16. Becker JW, Marcy AI, Rokosz LL, Axel MG, Burbaum JJ, Fitzgerald PM, Cameron PM, Esser CK, Hagmann WK, Hermes JD et al (1995) Stromelysin-1: three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme. Protein Sci 4:1966-1976
17. Matsuhashi T, Yamada N, Shinzawa H, Takahashi T (1996) Effect of alcohol on tumor growth of hepatocellular carcinoma with type C cirrhosis. Intern Med 35:443-448
18. Li T, Liang Z, Singanallur JV, Satogata TJ, Williams DC, Schulte RW (2006) Reconstruction for proton computed tomography by tracing proton trajectories: a Monte Carlo study. Med Phys 33:699-706
19. Park JA, Shin KS, Kim YW (2005) Polymorphism of matrix metalloproteinase-3 promoter gene as a risk factor for coronary artery lesions in Kawasaki disease. J Korean Med Sci 20:607-611
20. Itagaki M, Kubota T, Tai H, Shimada Y, Morozumi T, Yamazaki K (2004) Matrix metalloproteinase-1 and -3 gene promoter polymorphisms in Japanese patients with periodontitis. J Clin Periodontol 31:764-769
21. Shibata N, Ohnuma T, Higashi S, Usui C, Ohkubo T, Kitajima A, Ueki A, Nagao M, Arai H (2005) Genetic association between matrix metalloproteinase MMP-9 and MMP-3 polymorphisms and Japanese sporadic Alzheimer's disease. Neurobiol Aging 26:1011-1014
22. Schuppan D (1990) Structure of the extracellular matrix in normal and fibrotic liver: collagens and glycoproteins. Semin Liver Dis 10:1-10
23. Arthur MJ (1990) Matrix degradation in the liver. Semin Liver Dis 10:47-55
24. Emonard H, Grimaud JA (1990) Matrix metalloproteinases. A review. Cell Mol Biol 36:131-153
25. Borden P, Heller RA (1997) Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases. Crit Rev Eukaryot Gene Expr 7:159-178
26. Sciavolino PJ, Lee TH, Vilcek J (1994) Interferon-beta induces metalloproteinase mRNA expression in human fibroblasts. Role of activator protein-1. J Biol Chem 269:21627-21634
27. Sirum KL, Brinckerhoff CE (1989) Cloning of the genes for human stromelysin and stromelysin 2: differential expression in rheumatoid synovial fibroblasts. Biochemistry 28:8691-8698
28. Lichtinghagen R, Bahr MJ, Wehmeier M, Michels D, Haberkorn CI, Arndt B, Flemming P, Manns MP, Boeker KH (2003) Expression and coordinated regulation of matrix metalloproteinases in chronic hepatitis C and hepatitis C virus-induced liver cirrhosis. Clin Sci (Lond) 105:373-382
29. Okamoto K, Mimura K, Murawaki Y, Yuasa I (2005) Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease. J Gastroenterol Hepatol 20:1102-1108
30. Satsangi J, Chapman RW, Haldar N, Donaldson P, Mitchell S, Simmons J, Norris S, Marshall SE, Bell JI, Jewell DP, Welsh KI (2001) A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis. Gastroenterology 121:124-130
31. Lu SN, Wang JH, Liu SL, Hung CH, Chen CH, Tung HD, Chen TM, Huang WS, Lee CM, Chen CC, Changchien CS (2006) Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma. Cancer 107:2212-2222